60 Degrees Pharmaceuticals (SXTP) insider reports 658,629-share stake

Rhea-AI Filing Summary

Knight Therapeutics Inc. reports initial insider ownership in 60 Degrees Pharmaceuticals, Inc. (SXTP) as a ten percent owner. It holds 658,629 shares of common stock, $0.0001 par value per share, directly as of July 22, 2026, with no buy or sell transaction specified.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Knight Therapeutics Inc.

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock, $0.0001 par value per share	--	--	--

Holdings After Transaction: Common Stock, $0.0001 par value per share — 658,629 shares (Direct)

Key Figures

Common shares held: 658,629 shares Par value per share: $0.0001 per share Insider status: Ten percent owner +1 more

4 metrics

Common shares held 658,629 shares Directly held common stock reported as of July 22, 2026

Par value per share $0.0001 per share Par value of 60 Degrees Pharmaceuticals common stock

Insider status Ten percent owner Knight Therapeutics identified as a ten percent owner of SXTP

Holding entries reported 1 holding entry Number of non-derivative holding lines in this insider ownership report

Key Terms

ten percent owner, par value, direct or indirect ownership

3 terms

ten percent owner regulatory

"Reporting person is marked as a ten percent owner of the issuer"

par value financial

"Common Stock, $0.0001 par value per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

direct or indirect ownership regulatory

"Ownership type field indicates the shares are held directly"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/29/2026 - 04:06 PM Accepted by SEC EDGAR 07/29/2026 - 04:06 PM Learn about SEC filing dates

FAQ

How many SXTP shares does Knight Therapeutics report owning?

Knight Therapeutics reports owning 658,629 shares of 60 Degrees Pharmaceuticals common stock. These shares are held directly and represent insider ownership reported as of July 22, 2026, based on the company’s non-derivative holdings disclosure.

What class of SXTP securities does Knight Therapeutics hold?

Knight Therapeutics holds common stock of 60 Degrees Pharmaceuticals, with a stated par value of $0.0001 per share. The position reflects equity ownership in the issuer rather than derivative or debt instruments.

Is Knight Therapeutics a ten percent owner of SXTP?

Yes, Knight Therapeutics is identified as a ten percent owner of 60 Degrees Pharmaceuticals (SXTP. This status reflects that its reported holdings meet the regulatory threshold for a significant insider ownership position.

Does the Knight Therapeutics SXTP filing show any recent share purchases or sales?

No buy or sell transactions are specified; the report lists holding information only. It discloses Knight Therapeutics’ direct ownership of 658,629 SXTP common shares without detailing any contemporaneous acquisitions or dispositions.

Are Knight Therapeutics’ SXTP shares held directly or indirectly?

The 658,629 SXTP common shares are reported as held directly by Knight Therapeutics. The ownership type is coded as direct, rather than through an intermediate entity or indirect arrangement.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Knight Therapeutics Inc.

(Last) (First) (Middle)

600 - 100 BOUL. ALEXIS NIHON

(Street)

MONTREAL H4M 2P2

(City) (State) (Zip)

QUEBEC, CANADA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/22/2026

3. Issuer Name and Ticker or Trading Symbol
60 DEGREES PHARMACEUTICALS, INC. [ SXTP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.0001 par value per share	658,629	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Samira Sakhia President and Chief Executive Officer	07/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)